JOINN Laboratories (China) Co., Ltd. (06127.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

23.0x

Market Cap

HKD 16.94B

MomentumView details →

1D Return

−3.73%

YTD Return

+10.39%

RSI (14)

42.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

23.0x

Market Cap

HKD 16.94B

RSI (14)

42.8

MomentumView details →

1D Return

−3.73%

YTD Return

+10.39%

ProfitabilityView details →

Gross Margin

20.13%

Net Margin

58.08%

EBITDA Margin

26.66%

ROE (TTM)

10.95%

ROA (TTM)

9.07%

Asset Turnover

0.16x

GrowthView details →

Revenue YoY

−7.97%

EPS YoY

+236.72%

FCF YoY

+198.57%

Revenue CAGR 3Y

−9.92%

EPS CAGR 3Y

−41.62%

EBITDA YoY

+23.61%

EarningsView details →

EPS (Actual)

HKD 0.79

EPS Surprise

42.63%

Beats (12Q)

1/12

Next Q EPS Est

HKD 0.04

Avg Surprise (4Q)

42.63%

Rev Surprise

1.52%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

4.05x

Quick Ratio

2.89x

Div Yield

0.61%

Div Rate

HKD 0.14

Div Growth 1Y

+320.32%

Financials snapshotView financials →

Revenue (TTM)

1.69B

Net Income (TTM)

982.25M

Op. CF (TTM)

808.16M

Next earningsNov 4, 2026 →

Latest newsMore news →

Joinn Laboratories released its 2026 interim report on August 28, reporting net profit attributable to shareholders of 748 million yuan, up 1126.8% year-on-year, and revenue of 704 million yuan, up 5.27% year-on-year.8d ago

Joinn Laboratories (06127) issued a profit alert, expecting a significant increase in net profit for the first half of 2026 due to a rise in biological asset market prices.53d ago

Similar companies

Medpace Holdings, Inc.MEDP 安图生物603658.SH Revvity, Inc.RVTY Exact Sciences CorporationEXAS 金域医学603882.SH Charles River Laboratories International, Inc.CRL Find similar companies →

Latest newsMore news →

Joinn Laboratories released its 2026 interim report on August 28, reporting net profit attributable to shareholders of 748 million yuan, up 1126.8% year-on-year, and revenue of 704 million yuan, up 5.27% year-on-year.8d ago Joinn Laboratories (06127) issued a profit alert, expecting a significant increase in net profit for the first half of 2026 due to a rise in biological asset market prices.53d ago